Shaun McMeans

Currently holds a position at HTG Molecular Diagnostics Inc

Position	Company	Period
Chief Financial Officer, Senior Vice President	HTG Molecular Diagnostics Inc	Feb. 1, 2018 -
Vice President of Finance and Administration, Chief Financial Officer	HTG Molecular Diagnostics Inc	Feb. 1, 2012 - Feb. 1, 2018

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2016-04-05	2016-04-04	HTG Molecular Diagnostics Inc (HTGM)	PlS Planned sale	46,844 -19.3% 228.24 US$3,129,876	46,844 -19.3%	228.24	US$3,129,876
2016-04-05	2016-04-01	HTG Molecular Diagnostics Inc (HTGM)	PlS Planned sale	73,041 +13.4% 421.16 US$731,391	73,041 +13.4%	421.16	US$731,391
2016-03-14	2016-03-14	HTG Molecular Diagnostics Inc (HTGM)	PlS Planned sale	5,989 -31.0% 55.44 US$1,843,672	5,989 -31.0%	55.44	US$1,843,672
2016-03-14	2016-03-11	HTG Molecular Diagnostics Inc (HTGM)	PlS Planned sale	4,305 -16.6% 2.36 US$10,140	4,305 -16.6%	2.36	US$10,140
2016-03-09	2016-03-09	HTG Molecular Diagnostics Inc (HTGM)	PlS Planned sale	3,325 -10.9% 2.69 US$8,933	3,325 -10.9%	2.69	US$8,933